Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06773806 | CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE(CHLOECAPA) | recruiting | — | 3,600 | Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV | 1 | May 4, 2026 | clinicaltrials |
| NCT03067051 | Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System | recruiting | Phase 1 / Phase 2 | 66 | SpectraCure ABINDUSTRY | 4 | May 1, 2026 |
| clinicaltrials |
| NCT06807359 | Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System | recruiting | Phase 1 / Phase 2 | 43 | SpectraCure ABINDUSTRY | 2 | May 1, 2026 | clinicaltrials |
| NCT07562438 | Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 2 | 20 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT02526368 | Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer | recruiting | Early Phase 1 | 80 | Ivan de Kouchkovsky, MDOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07451795 | SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC(SHARP) | recruiting | Phase 2 | 66 | Fudan UniversityOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07559201 | Theranostic Applications of Radionuclides in Prostate Cancer | recruiting | N/A | 100 | Guilin Medical University, ChinaOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT06914544 | Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)(HYPOSTAT-III) | recruiting | N/A | 175 | University Hospital Schleswig-HolsteinOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT06363435 | AI-based Measurements of Tumour Burden in PSMA PET-CT | recruiting | — | 1,500 | Elin TragardhOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT07553754 | Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis(EXO-MET) | recruiting | — | 1,000 | Xijing HospitalOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT06242509 | Intestinal Akkermansia Muciniphila in Prostate Cancer(AkkPRO) | recruiting | — | 52 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT07552285 | The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center | recruiting | — | 300 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT07552922 | Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1(DINGO) | recruiting | N/A | 24 | St Vincent's Hospital, SydneyOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT06594926 | Working Out M0 Bipolar Androgen Therapy(WOMBAT) | recruiting | Phase 2 | 69 | Australian and New Zealand Urogenital and Prostate Cancer Trials GroupOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT03522064 | Bipolar Androgen Therapy + Carboplatin in mCRPC(HiTeCH) | recruiting | Phase 2 | 30 | St Vincent's Hospital, SydneyOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT06487507 | Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS) | recruiting | N/A | 20 | University of MiamiOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT07004582 | Lab Research Using Mini-tumors to Study Prostate Cancer Treatments(PR3DICT) | recruiting | — | 600 | Maastricht Radiation OncologyOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT05155501 | Clinical Trial of Approaches to Prostate Cancer Surgery(PARTIAL) | recruiting | N/A | 600 | Weill Medical College of Cornell UniversityOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT06172283 | Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy | recruiting | N/A | 30 | State University of New York at BuffaloOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT04638088 | Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy(EMUPRO) | recruiting | — | 2,000 | ElsanOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT04946370 | Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer | recruiting | Phase 1 / Phase 2 | 52 | Weill Medical College of Cornell UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07407283 | A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer | recruiting | Phase 1 / Phase 2 | 100 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 21, 2026 | clinicaltrials |
| NCT05969860 | At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer | recruiting | Phase 2 | 220 | Mayo ClinicOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07219147 | 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT05478694 | Outcomes of Focal Ablation for Prostate Cancer | recruiting | — | 225 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT06315595 | Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI | recruiting | — | 1,000 | Mayo ClinicOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07218913 | Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors | recruiting | Phase 1 | 44 | City of Hope Medical CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07484971 | Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria(CLIQQC) | recruiting | — | 2,000 | Société Algérienne de Formation et Recherche en OncologieOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07537010 | 3D1015 Injection for Patients With mCRPC | recruiting | Phase 1 | 8 | Chunjing YuOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT03620786 | HIFU for Focal Ablation of Prostate Tissue: An Observational Study | recruiting | — | 100 | University of California, Los AngelesOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT05497024 | Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing | recruiting | — | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT06171139 | Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer | recruiting | N/A | 80 | University of California, San FranciscoOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT06347705 | A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer | recruiting | Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT06439225 | Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes(OPTION-DDR) | recruiting | Phase 3 | 236 | Canadian Cancer Trials GroupNETWORK | 1 | Apr 16, 2026 | clinicaltrials |
| NCT04693377 | Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial | recruiting | N/A | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT06615752 | Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients | recruiting | Phase 1 / Phase 2 | 99 | Charles Drew University of Medicine and ScienceOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT06638931 | Agnostic Therapy in Rare Solid Tumors(ANTARES) | recruiting | Phase 2 | 28 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT07531329 | Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer(DEPICT) | recruiting | — | 1,000 | Xijing HospitalOTHER | 1 | Apr 15, 2026 | clinicaltrials |
| NCT05487846 | Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation | recruiting | N/A | 120 | Thomas Jefferson UniversityOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT05847166 | A Phase 2/3,PSMA-T4, Prostate Cancer | recruiting | N/A | 80 | NCBJ Polatom: Narodowe Centrum Badań Jądrowych PolatomINDUSTRY | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06044857 | PSMA PET Response Guided SabR in High Risk Pca | recruiting | Phase 1 | 20 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT06122584 | Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer | recruiting | Phase 3 | 380 | ABX advanced biochemical compounds GmbHINDUSTRY | 6 | Apr 14, 2026 | clinicaltrials |
| NCT06235697 | Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment(ASCENDE-SBRT) | recruiting | Phase 3 | 710 | Canadian Cancer Trials GroupNETWORK | 2 | Apr 14, 2026 | clinicaltrials |
| NCT04337580 | Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer(FASN) | recruiting | Phase 2 | 50 | Wake Forest University Health SciencesOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05313191 | Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors(ReRT) | recruiting | N/A | 1,800 | The New York Proton CenterOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06190899 | Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 / Phase 2 | 54 | Celcuity IncINDUSTRY | 4 | Apr 13, 2026 | clinicaltrials |
| NCT06610825 | Castrate Resistant Prostate Cancer Enhertu Therapy(CaRPET) | recruiting | Phase 2 | 60 | Washington D.C. Veterans Affairs Medical CenterFED | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07093177 | Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer | recruiting | N/A | 30 | University of UtahOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT05710861 | Cost-utility of Focal HIFU vs Prostatectomy(EMERHIT) | recruiting | N/A | 346 | University Hospital, BordeauxOTHER | 2 | Apr 9, 2026 | clinicaltrials |
| NCT07192120 | A Study of MHB048C in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 200 | Minghui Pharmaceutical (Hangzhou) LtdINDUSTRY | 1 | Apr 9, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 4, 2026source: clinicaltrials